We have located links that may give you full text access.
Conversion from acetate dialysate to citrate dialysate in a central delivery system for maintenance hemodialysis patients.
Kidney Research and Clinical Practice 2019 March 32
Background: The objective of this study was to compare the impact of citrate dialysate (CD) and standard acetate dialysate (AD) in hemodialysis by central delivery system (CDS) on heparin demand, and clinical parameters.
Methods: We retrospectively evaluated 75 patients on maintenance hemodialysis with CDS. Patients underwent hemodialysis with AD over a six-month period (AD period), followed by another six-month period using CD (CD period). Various parameters including mean heparin dosage, high sensitivity C-reactive protein (hsCRP), calcium-phosphate product (CaxP), intact parathyroid hormone (iPTH), and urea reduction ratio (URR) were collated at the end of each period.
Results: Patients were 60.5 ± 14.7 years old, of whom 62.7% were male. Patients required less heparin when receiving CD (AD period: 1,129 ± 1,033 IU/session vs. CD period: 787 ± 755 IU/session, P < 0.001). After the CD period (Δ CD ), pre-dialysis total CO2 increased to 1.21 ± 2.80 mmol/L, compared to -2.44 ± 2.96 mmol/L ( P < 0.001) after the AD period (Δ AD ). After the CD period, concentrations of iPTH (Δ AD : 73.04 ± 216.34 pg/mL vs. Δ CD : -106.66 ± 251.79 pg/mL, P < 0.001) and CaxP (Δ AD : 4.32 ± 16.63 mg2 /dL2 vs. Δ CD : -4.67 ± 15.27 mg2 /dL2 , P = 0.015) decreased. While hsCRP levels decreased after the CD period (Δ AD : 0.07 ± 4.09 mg/L vs. Δ CD : -0.75 ± 4.56 mg/L, P = 0.705), the change was statistically insignificant. URR remained above clinical guideline of 65% after both periods (Δ AD : 72.33 ± 6.92% vs. Δ CD period: 69.20 ± 4.49%, P = 0.046).
Conclusion: Our study confirmed that the use of CD in CDS required lower heparin doses compared to the use of AD. The use of CD also provided a more stable acid-base status.
Methods: We retrospectively evaluated 75 patients on maintenance hemodialysis with CDS. Patients underwent hemodialysis with AD over a six-month period (AD period), followed by another six-month period using CD (CD period). Various parameters including mean heparin dosage, high sensitivity C-reactive protein (hsCRP), calcium-phosphate product (CaxP), intact parathyroid hormone (iPTH), and urea reduction ratio (URR) were collated at the end of each period.
Results: Patients were 60.5 ± 14.7 years old, of whom 62.7% were male. Patients required less heparin when receiving CD (AD period: 1,129 ± 1,033 IU/session vs. CD period: 787 ± 755 IU/session, P < 0.001). After the CD period (Δ CD ), pre-dialysis total CO2 increased to 1.21 ± 2.80 mmol/L, compared to -2.44 ± 2.96 mmol/L ( P < 0.001) after the AD period (Δ AD ). After the CD period, concentrations of iPTH (Δ AD : 73.04 ± 216.34 pg/mL vs. Δ CD : -106.66 ± 251.79 pg/mL, P < 0.001) and CaxP (Δ AD : 4.32 ± 16.63 mg2 /dL2 vs. Δ CD : -4.67 ± 15.27 mg2 /dL2 , P = 0.015) decreased. While hsCRP levels decreased after the CD period (Δ AD : 0.07 ± 4.09 mg/L vs. Δ CD : -0.75 ± 4.56 mg/L, P = 0.705), the change was statistically insignificant. URR remained above clinical guideline of 65% after both periods (Δ AD : 72.33 ± 6.92% vs. Δ CD period: 69.20 ± 4.49%, P = 0.046).
Conclusion: Our study confirmed that the use of CD in CDS required lower heparin doses compared to the use of AD. The use of CD also provided a more stable acid-base status.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app